EUVIMEDEUVIMED entdecken
VergleichsstudieMultizentrische StudieRandomisierte kontrollierte StudieOpen Access

Balloon Angioplasty vs Medical Management for Intracranial Artery Stenosis

Xuan Sun, Yiming Deng, Yong Zhang, Ming Yang, Dapeng Sun, Thanh N Nguyen, Xu Tong, Guangge Peng, Aihua Liu, Yun Xu, Yunhu Wu, Xiaokun Geng und 28 weitere

JAMA · 01.10.2024 · 332 (13) · 1059

DOI: 10.1001/jama.2024.12829 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift JAMA, erschienen am 01.10.2024. Verfasst von Xuan Sun und 39 weiteren Autor:innen. Beteiligte Einrichtung: Interventional Neuroradiology, Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China. Hauptthemen laut MEDLINE: Angioplasty, Balloon, Fibrinolytic Agents, Intracranial Arteriosclerosis. Die Arbeit wurde bisher 104-mal zitiert (Crossref) und nennt 22 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Importance Previous randomized clinical trials did not demonstrate the superiority of endovascular stenting over aggressive medical management for patients with symptomatic intracranial atherosclerotic stenosis (sICAS). However, balloon angioplasty has not been investigated in a randomized clinical trial.

Objective

To determine whether balloon angioplasty plus aggressive medical management is superior to aggressive medical management alone for patients with sICAS. Design, Setting, and Participants A randomized, open-label, blinded end point clinical trial at 31 centers across China. Eligible patients aged 35 to 80 years with sICAS defined as recent transient ischemic attack (<90 days) or ischemic stroke (14-90 days) before enrollment attributed to a 70% to 99% atherosclerotic stenosis of a major intracranial artery receiving treatment with at least 1 antithrombotic drug and/or standard risk factor management were recruited between November 8, 2018, and April 2, 2022 (final follow-up: April 3, 2023).

Interventions

Submaximal balloon angioplasty plus aggressive medical management (n = 249) or aggressive medical management alone (n = 252). Aggressive medical management included dual antiplatelet therapy for the first 90 days and risk factor control. Main Outcomes and Measures The primary outcome was a composite of any stroke or death within 30 days after enrollment or after balloon angioplasty of the qualifying lesion or any ischemic stroke in the qualifying artery territory or revascularization of the qualifying artery after 30 days through 12 months after enrollment.

Results

Among 512 randomized patients, 501 were confirmed eligible (mean age, 58.0 years; 158 [31.5%] women) and completed the trial. The incidence of the primary outcome was lower in the balloon angioplasty group than the medical management group (4.4% vs 13.5%; hazard ratio, 0.32 [95% CI, 0.16-0.63]; P < .001). The respective rates of any stroke or all-cause death within 30 days were 3.2% and 1.6%. Beyond 30 days through 1 year after enrollment, the rates of any ischemic stroke in the qualifying artery territory were 0.4% and 7.5%, respectively, and revascularization of the qualifying artery occurred in 1.2% and 8.3%, respectively. The rate of symptomatic intracranial hemorrhage in the balloon angioplasty and medical management groups was 1.2% and 0.4%, respectively. In the balloon angioplasty group, procedural complications occurred in 17.4% of patients and arterial dissection occurred in 14.5% of patients. Conclusions and Relevance In patients with sICAS, balloon angioplasty plus aggressive medical management, compared with aggressive medical management alone, statistically significantly lowered the risk of a composite outcome of any stroke or death within 30 days or an ischemic stroke or revascularization of the qualifying artery after 30 days through 12 months. The findings suggest that balloon angioplasty plus aggressive medical management may be an effective treatment for sICAS, although the risk of stroke or death within 30 days of balloon angioplasty should be considered in clinical practice. Trial Registration ClinicalTrials.gov Identifier: NCT03703635

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Angioplasty, BalloonFibrinolytic AgentsIntracranial ArteriosclerosisAdultAgedAged, 80 and overFemaleHumansMaleMiddle AgedIschemic Attack, TransientIschemic StrokePlatelet Aggregation InhibitorsConstriction, PathologicTreatment Outcome

Substanzen

Fibrinolytic AgentsPlatelet Aggregation Inhibitors

Autor:innen und Institutionen

  • Interventional Neuroradiology, Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.
  • China National Clinical Research Center for Neurological Diseases, Beijing.
  • Department of Neurology, The Affiliated Hospital of Qingdao University, Shandong, China.
  • Departments of Neurology and Radiology, Boston Medical Center, Boston, Massachusetts.
  • Department of Neurology, Beijing Luhe Hospital, Capital Medical University, Beijing, China.
  • Department of Neurosurgery, Beijing Neurosurgical Institute, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.

Zitieren

APA

Sun, X., Deng, Y., Zhang, Y., Yang, M., Sun, D., Nguyen, T. N., Tong, X., Peng, G., Liu, A., Xu, Y., Wu, Y., Geng, X., Wang, Y., Li, T., Xing, S., Wu, W., Ji, Y., Yang, H., Wang, S., …, & BASIS Investigators (2024). Balloon Angioplasty vs Medical Management for Intracranial Artery Stenosis. JAMA, 332(13), 1059. https://doi.org/10.1001/jama.2024.12829

Vancouver

Sun X, Deng Y, Zhang Y, Yang M, Sun D, Nguyen TN, et al. Balloon Angioplasty vs Medical Management for Intracranial Artery Stenosis. JAMA. 2024;332(13):1059. doi:10.1001/jama.2024.12829

BibTeX
@article{Sun2024,
  author = {Sun, Xuan and Deng, Yiming and Zhang, Yong and Yang, Ming and Sun, Dapeng and Nguyen, Thanh N and Tong, Xu and Peng, Guangge and Liu, Aihua and Xu, Yun and Wu, Yunhu and Geng, Xiaokun and Wang, Yang and Li, Tianxiao and Xing, Shihui and Wu, Wei and Ji, Yunxiang and Yang, Hua and Wang, Shouchun and Gao, Xiaoping and Yang, Weimin and Zhao, Xingquan and Liu, Liping and Ma, Ning and Gao, Feng and Mo, Dapeng and Huo, Xiaochuan and Song, Ligang and Li, Xiaoqing and Zhang, Jingbo and He, Hongwei and Lv, Ming and Mu, Shiqing and Yu, Wengui and Liebeskind, David S and Amin-Hanjani, Sepideh and Wang, Yongjun and Wang, Yilong and Miao, Zhongrong and BASIS Investigators, BASIS Investigators},
  title = {Balloon Angioplasty vs Medical Management for Intracranial Artery Stenosis},
  journal = {JAMA},
  year = {2024},
  volume = {332},
  number = {13},
  pages = {1059},
  doi = {10.1001/jama.2024.12829}
}
Kostenlos starten →